Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Accentuates The Positives Of Heart Failure Drug Entresto At ACC

Related Content

Novartis' <em>Entresto</em>: Slow Uptake Expected Following Fast FDA Approval

Jul 13 2015

Tekturna’s Loss May Be Entresto’s Gain As Novartis Hopes For Change In The ATMOSPHERE

Apr 05 2016

Related Companies

Novartis AG

Amgen, Inc.

Cigna Corp.

Additional Topics

Clinical Trials Business Strategies Reimbursement

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window